116 related articles for article (PubMed ID: 3674731)
1. Serum protein binding of phenytoin, diazepam and propranolol in age-related decrease in renal function.
Tiula E; Elfving S
Ann Clin Res; 1987; 19(3):163-9. PubMed ID: 3674731
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
Tiula E; Haapanen EJ; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):469-75. PubMed ID: 3679617
[TBL] [Abstract][Full Text] [Related]
3. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
Tiula E; Tallgren LG; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
[TBL] [Abstract][Full Text] [Related]
4. Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy.
Krauer B; Nau H; Dayer P; Bischof P; Anner R
Br J Obstet Gynaecol; 1986 Apr; 93(4):322-8. PubMed ID: 3964607
[TBL] [Abstract][Full Text] [Related]
5. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
6. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
7. Effect of total drug concentration on the free fraction in uremic sera.
Tiula E; Neuvonen PJ
Ther Drug Monit; 1986; 8(1):27-31. PubMed ID: 3961893
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
[TBL] [Abstract][Full Text] [Related]
9. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
Terao N; Shen DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
[TBL] [Abstract][Full Text] [Related]
10. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
11. Effect of age and sex on the plasma binding of acidic and basic drugs.
Verbeeck RK; Cardinal JA; Wallace SM
Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
[TBL] [Abstract][Full Text] [Related]
12. Serum protein binding of sulfisoxazole and diazepam in patients with chronic obstructive pulmonary disease.
Guerrero J; García-Morillas M; Gil-Extremera B; Erill S
Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):255-8. PubMed ID: 3596851
[TBL] [Abstract][Full Text] [Related]
13. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
Belpaire FM; Chindavijak B; Bogaert MG
J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
[TBL] [Abstract][Full Text] [Related]
14. The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
McNamara PJ; Blouin RA; Brazzell RK
Pharm Res; 1988 May; 5(5):261-5. PubMed ID: 3149736
[TBL] [Abstract][Full Text] [Related]
15. [Binding of phenytoin to serum albumin in vitro and in vivo].
Pospísil J; Perlík F; Kordac V; Kolínová M
Cesk Farm; 1991 Dec; 40(6-7):200-2. PubMed ID: 1823294
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and pethidine using equilibrium dialysis and ultracentrifugation.
Verbeeck RK; Cardinal JA
Arzneimittelforschung; 1985; 35(6):903-6. PubMed ID: 4026915
[TBL] [Abstract][Full Text] [Related]
17. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
Battino D; Croci D; Mamoli D; Messina S; Perucca E
Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
[TBL] [Abstract][Full Text] [Related]
18. Variations in drug free fraction during alcohol withdrawal.
Sandor P; Naranjo CA; Khouw V; Sellers EM
Br J Clin Pharmacol; 1983 Apr; 15(4):481-6. PubMed ID: 6849785
[TBL] [Abstract][Full Text] [Related]
19. Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.
Benedek IH; Blouin RA; McNamara PJ
Br J Clin Pharmacol; 1984 Dec; 18(6):941-6. PubMed ID: 6529534
[TBL] [Abstract][Full Text] [Related]
20. The binding of chemically different psychotropic drugs to alpha 1-acid glycoprotein.
Schley J; Müller-Oerlinghausen B
Pharmacopsychiatria; 1983 May; 16(3):82-5. PubMed ID: 6611652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
